![The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy - ScienceDirect The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525505020307605-gr1.jpg)
The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy - ScienceDirect
![IJMS | Free Full-Text | Effects of Lacosamide Treatment on Epileptogenesis, Neuronal Damage and Behavioral Comorbidities in a Rat Model of Temporal Lobe Epilepsy IJMS | Free Full-Text | Effects of Lacosamide Treatment on Epileptogenesis, Neuronal Damage and Behavioral Comorbidities in a Rat Model of Temporal Lobe Epilepsy](https://www.mdpi.com/ijms/ijms-22-04667/article_deploy/html/images/ijms-22-04667-g001.png)
IJMS | Free Full-Text | Effects of Lacosamide Treatment on Epileptogenesis, Neuronal Damage and Behavioral Comorbidities in a Rat Model of Temporal Lobe Epilepsy
![Cognitive Effects of Lacosamide in Patients with Drug Refractory Focal Epilepsy: A Prospective Observational Study | International Journal of Innovative Research in Medical Science Cognitive Effects of Lacosamide in Patients with Drug Refractory Focal Epilepsy: A Prospective Observational Study | International Journal of Innovative Research in Medical Science](https://ijirms.in/public/journals/1/submission_1309_1388_coverImage_en_US.png)
Cognitive Effects of Lacosamide in Patients with Drug Refractory Focal Epilepsy: A Prospective Observational Study | International Journal of Innovative Research in Medical Science
![New Data on Vimpat® (lacosamide) C-V to be Presented at the 64th Annual Meeting of the American Epilepsy Society | Fierce Biotech New Data on Vimpat® (lacosamide) C-V to be Presented at the 64th Annual Meeting of the American Epilepsy Society | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/Brain_Khanchit%20Khirisutchalual_GettyImages-1331059443.jpg?VersionId=6ckvgNTYYuo0G72iy9dGr9PNB4KA0mVx)
New Data on Vimpat® (lacosamide) C-V to be Presented at the 64th Annual Meeting of the American Epilepsy Society | Fierce Biotech
![UCB's VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy UCB's VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy](https://mma.prnewswire.com/media/1336120/Vimpat.jpg?p=facebook)